Century Therapeutics shares nonclinical data on CNTY-813
- Presented nonclinical data at EASD 2026 on October 2, 2026.
- CNTY-813 showed glycemic control in diabetic mice for over 11 months.
- Five clinical-scale batches of CNTY-813 showed consistent product profiles.